Position in ANTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$117,815
+$117,278 QoQ
Shares Held
24,342
+9636.8% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 66 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in ANTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. ANTX ranks #268 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in ANTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $117,815 | 24,342 | Shares | Sole | 2026-08-12 | |
| 2024-06-30 | $537 | 250 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $812 | 250 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,122 | 250 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $4,020 | 250 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $14,254 | 1,677 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $115,577 | 11,710 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $96,081 | 10,082 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||